Beijing Konruns Pharmaceutical Co., Ltd.SSE: 603590

(603590)"Beijing Konruns Pharmaceutical Co., Ltd."Announcement on Repurchase and Cancellation of Restricted Shares Granted to Certain Incentive Participants but Not Yet Released from Trading Restrictions

· Issued by Beijing Konruns Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603590 · · 4 pages · Chinese

Summary by 6ix AI

Beijing Konruns Pharmaceutical Co., Ltd. announced the repurchase and cancellation of restricted shares granted to certain incentive participants that have not yet been released from trading restrictions. The total amount for the repurchase will be sourced from the company's own funds, and the share structure will be adjusted accordingly after the cancellation. This repurchase is not expected to significantly impact the company's financial status or operational performance.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603590beijing-konruns-pharmaceutical-co-ltdannouncement-on-repurchase-and-cancellation-of-restricted-shares-granted-to-certain-incentive-participants-but-not-yet-released-from-trading-restrictions

Release

Announcement on Repurchase and Cancellation of Restricted Shares Granted to Certain Incentive Participants but Not Yet Released from Trading Restrictions

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Beijing Konruns Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Beijing Konruns Pharmaceutical

Later from Beijing Konruns Pharmaceutical

All Beijing Konruns Pharmaceutical news releases